SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-24-033167
Filing Date
2024-08-19
Accepted
2024-08-19 17:27:22
Documents
5
Period of Report
2024-08-19

Document Format Files

Seq Description Document Type Size
1 formdef14a.htm DEF 14A 961737
2 formdef14a_001.jpg GRAPHIC 50460
3 formdef14a_002.jpg GRAPHIC 43837
4 proxy_001.jpg GRAPHIC 1247302
5 proxy_002.jpg GRAPHIC 1448165
  Complete submission text file 0001493152-24-033167.txt   4563138
Mailing Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540
Business Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540 609-375-2227
Sonnet BioTherapeutics Holdings, Inc. (Filer) CIK: 0001106838 (see all company filings)

IRS No.: 522102141 | State of Incorp.: DE | Fiscal Year End: 0930
Type: DEF 14A | Act: 34 | File No.: 001-35570 | Film No.: 241221888
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)